The relationship between occupational exposure to lead and manifestation of cardiovascular complications in persons with arterial hypertension

Toxicology and Applied Pharmacology

Volumn 249, Issue 1, 2010, Pages 41-46

  Poreba, Rafał ^a   Gać, Paweł ^a   Poreba, Małgorzata ^a   Andrzejak, Ryszard ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Ambulatory blood pressure monitoring; Arterial hypertension; Cardiovascular complication; Exposure to lead

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; LEAD; PROTOPORPHYRIN ZINC; BIOLOGICAL MARKER; PROTOPORPHYRIN;

ADULT; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; CARDIOVASCULAR DISEASE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL EXPOSURE; PULSE PRESSURE; SYSTOLIC BLOOD PRESSURE; BLOOD; COMPARATIVE STUDY; COMPLICATION; HYPERTROPHY, LEFT VENTRICULAR; LEAD POISONING; METALLURGY; MIDDLE AGED; RISK FACTOR;

ADULT; BIOLOGICAL MARKERS; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; LEAD POISONING; MALE; METALLURGY; MIDDLE AGED; OCCUPATIONAL EXPOSURE; PROTOPORPHYRINS; RISK FACTORS;

EID: 77957863616     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2010.08.012     Document Type: Article

References (28)

1. ACC/AHA ACC/AHA guidelines for the clinical application of echocardiography. A report of the American College of Cardiology/American Heart Association Task Force on assessment of diagnostic and therapeutic cardiovascular procedures (Subcommittee to Develop Guidelines for the Clinical Application of Echocardiography). Circulation 1990, 82:2323-2345.
2. Alderman M.H., Ooi W.L., Madhavan S., Cohen H. Blood pressure reactivity predicts myocardial infarction among treated hypertensive patients. J. Clin. Epidemiol. 1990, 43:859-866.
3. Andrzejak R., Poreba R., Poreba M., Pyszel A., Derkacz A., Gać P., Beck B., Steinmetz-Beck A. Ambulatory blood pressure monitoring and structural changes in carotid arteries in normotensive workers occupationally exposed to lead. J. Hypertens. 2006, 24(suppl.4):S171.
4. Apostoli P. Update on the subject of lead toxicology. Ann. Ist. Super. Sanita. 1998, 34:5-15.
5. Asmar R., Rudnichi A., Blacher J., London G.M., Safar M.E. Pulse pressure and aortic pulse wave are markers of cardiovascular risk in hypertensive populations. Am. J. Hypertens. 2001, 14:91-97.
6. Avolio A.P., Van Bortel L.M., Boutouyrie P., Cockcroft J.R., McEniery C.M., Protogerou A.D., Roman M.J., Safar M.E., Segers P., Smulyan H. Role of pulse pressure amplification in arterial hypertension: experts' opinion and review of the data. Hypertension 2009, 54:375-383.
7. Brunel P., Asmar R., Pannier B., Laurent S., Safar M. Pulse wave velocity and ambulatory blood pressure in essential arterial hypertension. Arch. Mal. Coeur. Vaiss. 1988, 81:235-239.
8. Chae C.U., Pfeffer M.A., Glynn R.J., Mitchell G.F., Taylor J.O., Hennekens C.H. Increased pulse pressure and risk of heart failure in the elderly. JAMA 1999, 281:634-639.
9. Clement D.L., De Buyzere M.L., De Bacquer D.A., de Leeuw P.W., Duprez D.A., Fagard R.H., Gheeraert P.J., Missault L.H., Braun J.J., Six R.O., Van Der Niepen P., O'Brien E. Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. N. Engl. J. Med. 2003, 348:2407-2415. Office versus Ambulatory Pressure Study Investigators.
10. Devereux R.B., Alonso D.R., Lutas E.M., Gottlieb G.J., Campo E., Sachs I., Reichek N. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am. J. Cardiol. 1986, 57:450-458.
11. Garvey L., Makaroun M.S., Muluk V.S., Webster M.W., Muluk S.C. Etiologic factors in progression of carotid stenosis: a 10-year study in 905 patients. J. Vasc. Surg. 2000, 31:31-38.
12. Goch A., Goch J.H. Lead-induced pathomechanisms of hypertension. Pol. Merkur. Lekarski. 2005, 18:351-353.
13. Hozawa A., Ohkubo T., Nagai K., Kikuya M., Matsubara M., Tsuji I., Ito S., Satoh H., Hisamichi S., Imai Y. Factors affecting the difference between screening and home blood pressure measurements: the Ohasama Study. J. Hypertens. 2001, 19:13-19.
14. Khattar R.S., Acharya D.U., Kinsey C., Senior R., Lahiri A. Longitudinal association of ambulatory pulse pressure with left ventricular mass and vascular hypertrophy in essential hypertension. J. Hypertens. 1997, 15:737-743.
15. Kikuya M., Hozawa A., Ohokubo T., Tsuji I., Michimata M., Matsubara M., Ota M., Nagai K., Araki T., Satoh H., Ito S., Hisamichi S., Imai Y. Prognostic significance of blood pressure and heart rate variabilities: the Ohasama study. Hypertension 2000, 36:901-906.
16. Madhavan S., Ooi W.L., Cohen H., Alderman M.H. Relation of pulse pressure and blood pressure reduction to the incidence of myocardial infarction. Hypertension 1994, 23:395-401.
17. Millar J.A., Lever A.F., Burke V. Pulse pressure as a risk factor for cardiovascular events in the MRC Mild Hypertension Trial. J. Hypertens. 1999, 17:1065-1072.
18. Pannier B., Brunel P., el Aroussy W., Lacolley P., Safar M.E. Pulse pressure and echocardiographic findings in essential hypertension. J. Hypertens. 1989, 7:127-132.
19. Poreba R., Gać P., Poreba M., Derkacz A., Pilecki W., Antonowicz-Juchniewicz J., Andrzejak R. Relationship between chronic exposure to lead, cadmium and manganese, blood pressure values and incidence of arterial hypertension. Med. Pr. 2010, 61:5-14.
20. Rosin A. The long-term consequences of exposure to lead. Isr. Med. Assoc. J. 2009, 11:689-694.
21. Safar M.E., London G.M. Therapeutic studies and arterial stiffness in hypertension: recommendations of the European Society of Hypertension. The Clinical Committee of Arterial Structure and Function. Working Group on Vascular Structure and Function of the European Society of Hypertension. J. Hypertens. 2000, 18:1527-1535.
22. Sander D., Kukla C., Klingelhöfer J., Winbeck K., Conrad B. Relationship between circadian blood pressure patterns and progression of early carotid atherosclerosis: a 3-year follow-up study. Circulation 2000, 102:1536-1541.
23. Staessen J.A., Thijs L., Fagard R., O'Brien E.T., Clement D., de Leeuw P.W., Mancia G., Nachev C., Palatini P., Parati G., Tuomilehto J., Webster J. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators. JAMA 1999, 282:539-546.
24. Van Bortel L.M., Struijker-Boudier H.A., Safar M.E. Pulse pressure, arterial stiffness, and drug treatment of hypertension. Hypertension 2001, 38:914-921.
25. Varnai V.M., Piasek M., Blanusa M., Sarić M.M., Kostial K. Succimer treatment during ongoing lead exposure reduces tissue lead in suckling rats. J. Appl. Toxicol. 2001, 21:415-416.
26. Vaziri N.D., Liang K., Ding Y. Increased nitric oxide inactivation by reactive oxygen species in led-induced hypertension. Kidney Int. 1999, 56:1492-1498.
27. Zanchetti A., Bond M.G., Hennig M., Neiss A., Mancia G., Dal Palù C., Hansson L., Magnani B., Rahn K.H., Reid J., Rodicio J., Safar M., Eckes L., Ravinetto R. Risk factors associated with alterations in carotid intima-media thickness in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis. J. Hypertens. 1998, 16:949-961.
28. Zureik M., Touboul P.J., Bonithon-Kopp C., Courbon D., Berr C., Leroux C., Ducimetière P. Cross-sectional and 4-year longitudinal associations between brachial pulse pressure and common carotid intima-media thickness in a general population. The EVA study. Stroke 1999, 30:550-555.